SB 0917 | Mandates insurance coverage for new phases of clinical trials undertaken for the treatment of cancer |
Sponsor: | Dougherty | Co-Sponsor(s) | ||
LR Number: | 2779S.01I | Fiscal Note: | 2779-01 | |
Committee: | Small Business, Insurance & Industrial Relations | |||
Last Action: | 01/15/04 - Second Read and Referred S Small Business, Insurance | Journal page: | S117 | |
and Industrial Relations Committee | ||||
Title: | ||||
Effective Date: | August 28, 2004 | |||
SB 917 - This act requires health insurance companies to
provide coverage for routine patient care costs incurred as the
result of phase I or II clinical trials undertaken to treat
cancer. Currently, Section 376.429, RSMo, requires coverage for
phases III or IV only.
LORIE TOWE